jagadakku
Posted - 36 minutes from now
@Ludlowj @HereForFunsies $BAYRY I've been watching this for a while because of the company and was shocked to see the price but there was a company I worked for once that cratered to sub 5 $BSX and then bounced back
.. point is, patience will win out. I'm still waiting to get in on this.. gluck and stay strong
masko77
Posted - 34 minutes from now
$BAYRY Bayer AG (BAYZF.PK) Thursday said that the Food and Drug Administration or FDA has accepted the company's supplemental new drug application (sNDA) for Nubeqa for the treatment of patients with metastatic hormone-sensitive prostate cancer (mHSPC).
The sNDA is based on results from Phase 3 ARANOTE trial, which showed Nubeqa plus androgen deprivation therapy (ADT) significantly reduced the risk of progression or death in mHSPC patients when compared to placebo plus ADT. Further, no new safety signals were observed.
Nubeqa, in combination with docetaxel, is currently indicated for the treatment of non-metastatic castration-resistant prostate cancer (nmCRPC).
AanoldMcFace
Posted - 4 hours ago
$BAYRY absolute madness, how can something be red every day with no relief in between
HereForFunsies
Posted - 15 hours ago
$BAYRY what can you do lol if this is determined to crater, let the average down continue. Substantially lowering my buys for probably the next year or two because the investment will be better elsewhere, but long term this should eventually do something lol
Ludlowj
Posted - 17 hours ago
$BAYRY ceo has lost trust. Break it up. I don’t know the intrinsic value of this or cash per share. This smells like one of those great long term value stocks I read about.
masko77
Posted - 19 hours ago
$BAYRY Jefferies lowered target price to 22eur (hold), shit!
Millones
Posted - 21 hours ago
$BAYRY Adding a little more today.
Hekatontarch
Posted - 21 hours ago
$BAYRY This price action is mindblowing. Haven't been hurt this bad on a stock in a long time.
Blatter
Posted - 21 hours ago
$BAYRY 👊🚀💲
https://www.zacks.com/stock/news/2372721/bayer-acquires-rights-for-cardiovascular-drug-from-cytk-in-japan
AanoldMcFace
Posted - 1 day ago
$BAYRY a green day for once? NOPE.
HedgeTrade
Posted - 1 day ago
$BAYRY Doubled my position
masko77
Posted - 1 day ago
$BAYRY Insider buying (don't know whether it is the same buy that @NobleSpeculator mentioned). Bayer Aktiengesellschaft: Managers' transactions announcement according to article 19 MAR Alberto Weisser - a member of the administrative or supervisory body, purchased 233,962.11 EUR volume.
zmanx
Posted - 1 day ago
$CYTK nice AH’s news with $BAYRY license deal ! Still riding the 🌊 with my last few I’m holding here.
Article_AI
Posted - 1 day ago
$BAYRY Bayer acquires rights to Cytokinetics' heart drug in Japan Bayer on Tuesday struck a collaboration deal with U.S. biotech firm Cytokinetics to acquire certain rights in Japan to an experimental heart drug, as the German group strengthens its cardiovascular business with smaller deals. https://www.stck.pro/news/BAYRY/93541502/
DonCorleone77
Posted - 2 days ago
$CYTK $BAYRY Cytokinetics, Bayer enter collaboration and license pact for aficamten in Japan Cytokinetics (CYTK) and Bayer (BAYRY) announced they have entered into a collaboration and license agreement for the exclusive development and commercialization of aficamten in Japan for the treatment of patients with obstructive and non-obstructive hypertrophic cardiomyopathy, or HCM, subject to certain reserved development rights of Cytokinetics. Aficamten is a next-in-class cardiac myosin inhibitor for the potential treatment of patients with HCM. Cytokinetics will receive an upfront payment of EUR 50M and is eligible to receive up to an additional EUR 90M upon the achievement of milestones through commercial launch, including EUR 20M which are near-term. Cytokinetics is also eligible to receive up to EUR 490M in commercial milestone payments upon the achievement by Bayer of certain sales milestones, and tiered royalties on net sales of aficamten in Japan. This collaboration leverages Cytokinetics' broad development program of aficamten and Bayer's regional capabilities and expertise in the development and commercialization of therapies to treat cardiovascular diseases of unmet need for the benefit of patients in Japan. Under the joint development plan, Bayer will conduct a Phase 3 clinical trial in Japanese patients with obstructive HCM and Cytokinetics will expand ACACIA-HCM, the ongoing Phase 3 clinical trial of aficamten in patients with non-obstructive HCM, into Japan to support the potential marketing authorization of aficamten in Japan and CEDAR-HCM, its ongoing study for a pediatric population of patients with obstructive HCM.
AZ_09
Posted - 2 days ago
$BAYRY MAHA will send this to below 3...
Blatter
Posted - 2 days ago
$BAYRY 💲💲🚀
Browndog78
Posted - 2 days ago
$BAYRY Been watching all year considering an entry point but, like passing on getting a barbed wire tattoo around my arm in the nineties, THANK GOD I DIDN'T!!!
AanoldMcFace
Posted - 2 days ago
$BAYRY look at that, plummeting again. Owning this is kinda hard on you mentally.
rsmracks
Posted - 3 days ago
$BAYRY Bayer AG ADR (BAYRY) has a forward price-to-earnings (PE) ratio of 4.08
Extremely undervalued. The turnaround will happen. Continue accumulating and be patient. https://m.investing.com/news/stock-market-news/bayer-cuts-fy-operating-earnings-outlook-on-weak-agriculture-markets-3715459?ampMode=1
Blatter
Posted - 4 days ago
$BAYRY amazing 🤩 on Monday this must be received positively on the stock market, that something like this doesn't come straight into the news/daily news!? If Bayer has to pay, then it will be spread loudly. Is there anyone here who works for a daily newspaper?
Blatter
Posted - 4 days ago
$BAYRY At the last win in court in Philadelphia in August, Bayer rose by + 10% and thus the shorties are being beaten👊😀💲
Blatter
Posted - 5 days ago
$BAYRY 💪🚀💲
https://www.businesswire.com/news/home/20241115524530/en/3rd-Philadelphia-Jury-Finds-in-Favor-of-Monsanto-in-Roundup-Trial
Article_AI
Posted - 5 days ago
$BAYRY Bayer shareholders call on CEO to stem the tide of bad news Some Bayer investors say CEO Bill Anderson should speed up turnaround efforts, including boosting efficiency and drug development, to restore confidence and revive the company's share price that hit 20-year lows after its shock warning this week. https://www.stck.pro/news/BAYRY/93166462/
QEInfinity
Posted - 6 days ago
$BAYRY Well, I don't know where the bottom is here anymore but I would maintain that the long term picture isn't as bleak as the share price indicates. At least another year without much to look forward to other than putting the past behind them, but they will come out on the other side eventually and people who accumulate with a very long term mindset will be rewarded for patience.
NavalnyTheGreat
Posted - 6 days ago
$BAYRY @HereForFunsies This still makes me laugh
rsmracks
Posted - 6 days ago
$BAYRY They may be short for now, but these type bets have to be covered and can easily send the share price much higher when it turns. I will continue accumulating share count into 2025. https://www.marketscreener.com/quote/stock/BAYER-AG-436063/news/US-hedge-fund-makes-a-bet-on-falling-Bayer-share-prices-48358452/
AanoldMcFace
Posted - 1 week ago
$BAYRY this fkin stonk is moving like going bankrupt or something. HEAVILY red every day, sellers just pile in left and right. Absolutely disgusting, this moves like a Chinese EV stock.
Ludlowj
Posted - 1 week ago
$BAYRY break it up now. Waiting is delusional.
